Butalbital, Acetaminophen And Caffeine 13925-0535
Product NDC
13925-0535- Manufacturer
- Seton Pharmaceuticals Llc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- March 2, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA214087
Active Ingredients
| Ingredient | Strength |
|---|---|
| Acetaminophen | 300 mg/1 |
| Butalbital | 50 mg/1 |
| Caffeine | 40 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Methylxanthine [EPC]Barbiturate [EPC]
Packaging Options(1)
100 CAPSULE in 1 BOTTLE (13925-535-01)